Skip to main content
Erschienen in: Familial Cancer 2/2015

01.06.2015 | Original Article

Comparison of proctocolectomy and ileal pouch-anal anastomosis to colectomy and ileorectal anastomosis in familial adenomatous polyposis

verfasst von: L. Koskenvuo, H. Mustonen, L. Renkonen-Sinisalo, H. J. Järvinen, A. Lepistö

Erschienen in: Familial Cancer | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Prophylactic surgical options for familial adenomatous polyposis (FAP) are either colectomy and ileorectal anastomosis (IRA) or proctocolectomy and ileal pouch-anal anastomosis (IPAA). The aim of this study was to analyse the short-term and long-term outcomes of these two operative techniques. All patients with FAP in Finland have been prospectively recorded in a database since 1963 were retrospectively reviewed in this analysis. Altogether 140 (61 %) colectomies with IRA and 88 (39 %) proctocolectomies with IPAA have been performed. Complications occurred in 28 (21 %) patients after IRA and in 26 (30 %) patients after IPAA. There were 15 (11 %) severe complications for IRA and 5 (6 %) for IPAA. Twenty-one (15 %) patients of the IRA group ended up in conventional ileostomy whereas 3 (3.4 %) patients of the IPAA group had their ileal reservoir converted to an ileostomy (p = 0.01). Cumulative survival for IRA was lower than for the IPAA (p = 0.03), but if accounting only for operations made after the IPAA era had commenced, there was no significant difference. IPAA was associated with improved long-term survival without an increase in postoperative complications. The risk of death after colectomy and IRA seemed to be predominantly related to the remaining risk of rectal cancer. Therefore, we favour proctocolectomy with IPAA as the prophylactic surgical procedure for FAP with intermediate or severe polyposis.
Literatur
1.
Zurück zum Zitat Bussey HJR (1975) Familial polyposis coli. Family studies, histopathology, differential diagnosis and results of treatment. Johns Hopkins University Press, Baltimore Bussey HJR (1975) Familial polyposis coli. Family studies, histopathology, differential diagnosis and results of treatment. Johns Hopkins University Press, Baltimore
2.
Zurück zum Zitat Campos FG, Perez RO, Imperiale AR, Seid VE, Nahas SC, Cecconello I (2009) Surgical treatment of familial adenomatous polyposis: ileorectal anastomosis or restorative proctolectomy? Arq Gastroenterol 46:294–299CrossRefPubMed Campos FG, Perez RO, Imperiale AR, Seid VE, Nahas SC, Cecconello I (2009) Surgical treatment of familial adenomatous polyposis: ileorectal anastomosis or restorative proctolectomy? Arq Gastroenterol 46:294–299CrossRefPubMed
3.
Zurück zum Zitat Nieuwenhuis MH, Bulow S, Bjork J et al (2009) Genotype predicting phenotype in familial adenomatous polyposis: a practical application to the choice of surgery. Dis Colon Rectum 52:1259–1263CrossRefPubMed Nieuwenhuis MH, Bulow S, Bjork J et al (2009) Genotype predicting phenotype in familial adenomatous polyposis: a practical application to the choice of surgery. Dis Colon Rectum 52:1259–1263CrossRefPubMed
4.
Zurück zum Zitat Vasen HF, van der Lujit RB, Slors JF et al (1996) Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis. Lancet 17:433–435CrossRef Vasen HF, van der Lujit RB, Slors JF et al (1996) Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis. Lancet 17:433–435CrossRef
5.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6,336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedCentralPubMed Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6,336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedCentralPubMed
6.
Zurück zum Zitat Yamaguchi T, Yamamoto S, Fujita S, Akasu T, Moriya Y (2010) Long-term outcome of metachronous rectal cancer following ileorectal anastomosis for familial adenomatous polyposis. J Gastrointest Surg 14:500–505CrossRefPubMed Yamaguchi T, Yamamoto S, Fujita S, Akasu T, Moriya Y (2010) Long-term outcome of metachronous rectal cancer following ileorectal anastomosis for familial adenomatous polyposis. J Gastrointest Surg 14:500–505CrossRefPubMed
7.
Zurück zum Zitat Church J, Burke C, McGannon E, Pastean O, Clark B (2003) Risk of rectal cancer in patients after colectomy and ileorectal anastomosis for familial adenomatous polyposis: a function of available surgical options. Dis Colon Rectum 46:1175–1181CrossRefPubMed Church J, Burke C, McGannon E, Pastean O, Clark B (2003) Risk of rectal cancer in patients after colectomy and ileorectal anastomosis for familial adenomatous polyposis: a function of available surgical options. Dis Colon Rectum 46:1175–1181CrossRefPubMed
8.
Zurück zum Zitat Bulow S, Bulow C, Vasen H, Jarvinen H, Bjork J, Christensen IJ (2008) Colectomy and ileorectal anastomosis is still an option for selected patients with familial adenomatous polyposis. Dis Colon Rectum 51:1318–1323CrossRefPubMed Bulow S, Bulow C, Vasen H, Jarvinen H, Bjork J, Christensen IJ (2008) Colectomy and ileorectal anastomosis is still an option for selected patients with familial adenomatous polyposis. Dis Colon Rectum 51:1318–1323CrossRefPubMed
9.
Zurück zum Zitat Aziz O, Athanasiou T, Fazio VW et al (2006) Meta-analysis of observational studies of ileorectal versus ileal pouch-anal anastomosis for familial adenomatous polyposis. Br J Surg 93:407–417CrossRefPubMed Aziz O, Athanasiou T, Fazio VW et al (2006) Meta-analysis of observational studies of ileorectal versus ileal pouch-anal anastomosis for familial adenomatous polyposis. Br J Surg 93:407–417CrossRefPubMed
10.
Zurück zum Zitat Kartheuser A, Stangherlin P, Brandt D, Remue C, Sempoux C (2006) Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited. Fam Cancer 5:241–260CrossRefPubMed Kartheuser A, Stangherlin P, Brandt D, Remue C, Sempoux C (2006) Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited. Fam Cancer 5:241–260CrossRefPubMed
11.
Zurück zum Zitat Sinha A, Tekkis PP, Rashid S, Phillips RK, Clark SK (2010) Risk factors for secondary proctectomy in patients with familial adenomatous polyposis. Br J Surg 97:1710–1715CrossRefPubMed Sinha A, Tekkis PP, Rashid S, Phillips RK, Clark SK (2010) Risk factors for secondary proctectomy in patients with familial adenomatous polyposis. Br J Surg 97:1710–1715CrossRefPubMed
12.
Zurück zum Zitat de Campos FG, Perez RO, Imperiale AR, Seid VE, Nahas SC, Cecconello I (2010) Evaluating causes of death in familial adenomatous polyposis. J Gastrointest Surg 14:1943–1949CrossRefPubMed de Campos FG, Perez RO, Imperiale AR, Seid VE, Nahas SC, Cecconello I (2010) Evaluating causes of death in familial adenomatous polyposis. J Gastrointest Surg 14:1943–1949CrossRefPubMed
13.
Zurück zum Zitat da Luz Moreira A, Church JM, Burke CA (2009) The evolution of prophylactic colorectal surgery for familial adenomatous polyposis. Dis Colon Rectum 52:1481–1486CrossRef da Luz Moreira A, Church JM, Burke CA (2009) The evolution of prophylactic colorectal surgery for familial adenomatous polyposis. Dis Colon Rectum 52:1481–1486CrossRef
14.
Zurück zum Zitat Valanzano R, Ficari F, Curia MC et al (2007) Balance between endoscopic and genetic information in the choice of ileorectal anastomosis for familial adenomatous polyposis. J Surg Oncol 95:28–33CrossRefPubMed Valanzano R, Ficari F, Curia MC et al (2007) Balance between endoscopic and genetic information in the choice of ileorectal anastomosis for familial adenomatous polyposis. J Surg Oncol 95:28–33CrossRefPubMed
15.
Zurück zum Zitat Nieuwenhuis MH, Vasen HF (2007) Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit Rev Oncol-Hematol 61:153–161CrossRefPubMed Nieuwenhuis MH, Vasen HF (2007) Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit Rev Oncol-Hematol 61:153–161CrossRefPubMed
16.
Zurück zum Zitat Olsen KO, Juul S, Bulow S et al (2003) Female fecundity before and after operation for familial adenomatous polyposis. Br J Surg 90:227–231CrossRefPubMed Olsen KO, Juul S, Bulow S et al (2003) Female fecundity before and after operation for familial adenomatous polyposis. Br J Surg 90:227–231CrossRefPubMed
17.
Zurück zum Zitat Nieuwenhuis MH, Douma KF, Bleiker EM, Bemelman WA, Aaronson NK, Vasen HF (2010) Female fertility after colorectal surgery for familial adenomatous polyposis: a nationwide cross-sectional study. Ann Surg 252:341–344CrossRefPubMed Nieuwenhuis MH, Douma KF, Bleiker EM, Bemelman WA, Aaronson NK, Vasen HF (2010) Female fertility after colorectal surgery for familial adenomatous polyposis: a nationwide cross-sectional study. Ann Surg 252:341–344CrossRefPubMed
18.
Zurück zum Zitat Vasen HF, Moslein G, Alonso A et al (2008) Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57:704–713CrossRefPubMed Vasen HF, Moslein G, Alonso A et al (2008) Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57:704–713CrossRefPubMed
19.
Zurück zum Zitat von Roon AC, Tekkis PP, Lovegrove RE, Neale KF, Phillips RK, Clark SK (2008) Comparison of outcomes of ileal pouch-anal anastomosis for familial adenomatous polyposis with and without previous ileorectal anastomosis. Br J Surg 95:494–498CrossRef von Roon AC, Tekkis PP, Lovegrove RE, Neale KF, Phillips RK, Clark SK (2008) Comparison of outcomes of ileal pouch-anal anastomosis for familial adenomatous polyposis with and without previous ileorectal anastomosis. Br J Surg 95:494–498CrossRef
20.
Zurück zum Zitat Penna C, Kartheuser A, Parc R et al (1993) Secondary proctectomy and ileal pouch-anal anastomosis after ileorectal anastomosis for familial adenomatous polyposis. Br J Surg 80:1621–1623CrossRefPubMed Penna C, Kartheuser A, Parc R et al (1993) Secondary proctectomy and ileal pouch-anal anastomosis after ileorectal anastomosis for familial adenomatous polyposis. Br J Surg 80:1621–1623CrossRefPubMed
21.
Zurück zum Zitat Church JM, Xhaja X, Warrier SK et al (2014) Desmoid tumors do not prevent procetomy following abdominal colectomy and ileorectal anastomosis in patients with familial adenomatous polyposis. Dis Colon Rectum 57:343–347CrossRefPubMed Church JM, Xhaja X, Warrier SK et al (2014) Desmoid tumors do not prevent procetomy following abdominal colectomy and ileorectal anastomosis in patients with familial adenomatous polyposis. Dis Colon Rectum 57:343–347CrossRefPubMed
22.
Zurück zum Zitat Van Duijvendijk P, Slors JF, Taat CW et al (2000) Quality of life after total colectomy with ileorectal anastomosis or proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis. Br J Surg 87:590–596CrossRefPubMed Van Duijvendijk P, Slors JF, Taat CW et al (2000) Quality of life after total colectomy with ileorectal anastomosis or proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis. Br J Surg 87:590–596CrossRefPubMed
23.
Zurück zum Zitat Hassan I, Chua HK, Wolff BG et al (2005) Quality of life after ileal pouch-anal anastomosis and ileorectal anastomosis in patients with familial adenomatous polyposis. Dis Colon Rectum 48:2032–2037CrossRefPubMed Hassan I, Chua HK, Wolff BG et al (2005) Quality of life after ileal pouch-anal anastomosis and ileorectal anastomosis in patients with familial adenomatous polyposis. Dis Colon Rectum 48:2032–2037CrossRefPubMed
Metadaten
Titel
Comparison of proctocolectomy and ileal pouch-anal anastomosis to colectomy and ileorectal anastomosis in familial adenomatous polyposis
verfasst von
L. Koskenvuo
H. Mustonen
L. Renkonen-Sinisalo
H. J. Järvinen
A. Lepistö
Publikationsdatum
01.06.2015
Verlag
Springer Netherlands
Erschienen in
Familial Cancer / Ausgabe 2/2015
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-014-9773-9

Weitere Artikel der Ausgabe 2/2015

Familial Cancer 2/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.